S Keith Anderson Selected Research

S Keith Anderson Research Topics

Disease

19	Neoplasms (Cancer) 12/2022 - 01/2008
14	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 02/2012
6	Brain Neoplasms (Brain Tumor) 12/2022 - 01/2010
5	Breast Neoplasms (Breast Cancer) 03/2015 - 12/2010
4	Prostatic Neoplasms (Prostate Cancer) 03/2011 - 01/2008
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2017
3	Glioma (Gliomas) 11/2019 - 12/2010
3	Disease Progression 01/2018 - 01/2008
2	Cognitive Dysfunction 01/2023 - 07/2016
1	Oligodendroglioma 01/2021
1	Necrosis 01/2021
1	Measles 01/2021
1	Infections 10/2018
1	Hematologic Neoplasms (Hematological Malignancy) 10/2018
1	Neutropenia 01/2018
1	Hyperglycemia 01/2018
1	Fatigue 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2017
1	Brain Diseases (Brain Disorder) 01/2017
1	Astrocytoma (Pilocytic Astrocytoma) 12/2015
1	Hypoxia (Hypoxemia) 09/2013
1	Osteosarcoma (Osteogenic Sarcoma) 12/2010
1	Leukemia 12/2010
1	Seizures (Absence Seizure) 12/2010

Drug/Important Bio-Agent (IBA)

7	Temozolomide (Temodar)FDA LinkGeneric 11/2023 - 06/2013
5	Bevacizumab (Avastin)FDA Link 01/2022 - 09/2013
5	RNA (Ribonucleic Acid)IBA 10/2018 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2008
3	Trastuzumab (Herceptin)FDA Link 03/2015 - 02/2011
3	ParaffinIBA 01/2013 - 01/2008
3	AndrogensIBA 03/2011 - 04/2009
2	AntigensIBA 01/2022 - 01/2021
2	Vorinostat FDA Link 01/2018 - 02/2012
2	Sorafenib (BAY 43-9006)FDA Link 01/2018 - 09/2013
2	Formaldehyde (Formol)FDA Link 01/2013 - 12/2010
2	Androgen Receptors (Androgen Receptor)IBA 03/2011 - 12/2009
2	human ERBB2 proteinIBA 02/2011 - 12/2010
1	EnzymesIBA 01/2023
1	ImmunosorbentsIBA 01/2023
1	VaccinesIBA 01/2022
1	carotuximabIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Bacterial AntigensIBA 01/2021
1	Phenylalanine (L-Phenylalanine)FDA Link 01/2021
1	Dasatinib (BMS 354825)FDA Link 11/2019
1	src-Family KinasesIBA 11/2019
1	Janus Kinase InhibitorsIBA 10/2018
1	ruxolitinibIBA 10/2018
1	InterferonsIBA 10/2018
1	raf KinasesIBA 01/2018
1	Mitogen-Activated Protein KinasesIBA 01/2018
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2018
1	TOR Serine-Threonine KinasesIBA 01/2018
1	temsirolimus FDA Link 01/2018
1	Everolimus FDA Link 09/2015
1	ErbB Receptors (EGF Receptor)IBA 03/2015
1	Messenger RNA (mRNA)IBA 03/2015
1	Therapeutic UsesIBA 09/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2013
1	Complementary DNA (cDNA)IBA 01/2013
1	Recombinant DNA (Recombinant DNA Research)IBA 01/2013
1	Lapatinib (GW572016)FDA Link 01/2013
1	IntegrinsIBA 01/2013
1	Proteasome InhibitorsIBA 02/2012
1	Histone Deacetylases (Histone Deacetylase)IBA 02/2012
1	Bortezomib (Velcade)FDA Link 02/2012
1	Histone Deacetylase InhibitorsIBA 02/2012
1	Cyclin A2IBA 12/2010
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2010
1	Proteins (Proteins, Gene)FDA Link 12/2010
1	Estrogen ReceptorsIBA 12/2010
1	SurvivinIBA 12/2010
1	Wnt-5a ProteinIBA 12/2010
1	GRB7 Adaptor ProteinIBA 12/2010
1	Levetiracetam (Keppra)FDA LinkGeneric 12/2010
1	Phenytoin (Dilantin)FDA LinkGeneric 12/2010
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2010
1	Cholestenone 5 alpha-Reductase (5 alpha-Reductase)IBA 12/2009
1	Dutasteride (Avodart)FDA Link 12/2009
1	LigandsIBA 12/2009
1	5-alpha Reductase InhibitorsIBA 12/2009

Therapy/Procedure

12	Radiotherapy 01/2023 - 09/2015
7	Therapeutics 12/2022 - 01/2008
2	Drug Therapy (Chemotherapy) 01/2018 - 06/2013
1	Conformal Radiotherapy 11/2023
1	Chemoradiotherapy 11/2023
1	Immunotherapy 01/2021
1	Contraindications 01/2021
1	Oncolytic Virotherapy 10/2018
1	Cognitive Training 03/2015
1	Combination Drug Therapy (Combination Chemotherapy) 03/2015
1	Ligation 01/2013
1	Chemoprevention 12/2009
1	Prostatectomy (Retropubic Prostatectomy) 01/2008